Blog

Johnson’s Baby has strengthened its long-running neonatal care initiative by supporting the training of more than two lakh healthcare workers across India to handle birth asphyxia, one of the leading causes of newborn deaths within 24 hours of birth. The programme, running for 16 years in partnership with a leading paediatrician association, focuses on Neonatal Resuscitation life-saving interventions needed in the first minute of birth. India records nearly 1.25 lakh newborn deaths annually due to conditions such as birth asphyxia, which is preventable with timely action. States like Uttar Pradesh and Bihar have shown progress, but reducing neonatal mortality remains…

Dr. Moode Jayanth,Consultant Surgical Gastroenterologist & Robotic Surgeon, Yashoda Hospitals, Hyderabad says, It has long been believed that cirrhosis, a chronic liver condition marked by liver tissue scarring, is permanent. Recent studies, however, show that the liver can regenerate and cure itself under specific circumstances, providing individuals with this severe condition with new hope. The final stage of increasing liver damage is cirrhosis, which is frequently brought on by autoimmune diseases, fatty liver disease, heavy alcohol use, and hepatitis B and C. Scar tissue from repeated injuries impairs liver function and may result in potentially fatal consequences. Liver transplantation was…

Samsung’s latest foldable smartphone, the Galaxy Z TriFold, has begun drawing strong attention from technology enthusiasts, with interest rising in major markets including Kolkata as the device goes on sale globally. The Galaxy Z TriFold marks a major step in foldable smartphone design, offering a 10-inch Dynamic AMOLED 2X display when unfolded twice. The large screen supports multitasking by allowing users to run up to three portrait-sized apps simultaneously, making it suitable for professionals and content creators. Samsung has equipped the device with a 6.5-inch outer display, ensuring smooth visuals even when folded. Features such as Vision Booster adjust colour…

Winter comes with cozy nights and festive cheer, yet it also brings a familiar challenge for many: dry, dull, and sensitive skin. The cold air pulls moisture from our skin, leaving it susceptible to flakiness and irritation. Topical skincare can help, but lasting nourishment starts from within. She explains that winter dryness is not only a skincare concern but also a nutritional one. She highlights the importance of incorporating foods rich in protein, healthy fats, vitamin E, and omega-3, such as fatty fish and California Almonds. Including almonds in your daily diet can nourish the skin from within, helping it…

Samsung’s Solve for Tomorrow (SFT) 2025 programme has spotlighted India’s young innovators who are using artificial intelligence to address real-world challenges in health, hygiene, and emotional wellbeing. The nationwide initiative, conducted in partnership with IIT Delhi, invited thousands of students to design AI-first solutions to improve healthcare accessibility. Several standout teams developed practical tools for early detection, mobility support, and inclusive communication. Projects included an AI model to detect subclinical silicosis (Alchemist), a low-cost bionic hand (BRHM), AI glasses converting speech to text (Hear Bright), and a predictive breast health app (Pink Brigadiers). The theme winner, Paraspeak, developed by 16-year-old…

Corona Remedies is scheduled to make its stock market debut on Monday, December 15, 2025, with grey market trends pointing to a strong listing. The IPO attracted robust investor interest during its three-day subscription window, closing with an overall subscription of 137.04 times the shares available. Based in Gujarat, the pharmaceutical company focuses on developing and manufacturing products across key therapeutic segments such as women’s healthcare and cardio-diabetes. Ahead of the listing, market sentiment remains upbeat. As of Sunday, December 14, the grey market premium for the Corona Remedies IPO stood at ₹295 per share. With the upper issue price…

HRS Aluglaze Ltd has announced that it plans to raise up to ₹50.92 crore through its Initial Public Offering (IPO), which will open for subscription on December 11 and close on December 15. The shares will be listed on the BSE SME platform after the public issue. The company will issue 53.04 lakh equity shares in a price band of ₹94 to ₹96 per share. The minimum application size for retail investors is 2,400 shares, equivalent to a minimum investment of ₹2,30,400 at the upper price band. According to the company, the funds raised will be used for setting up…